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Introduction 
 
1. Atopic dermatitis 
 Atopic dermatitis (AD) is a chronically relapsing inflammatory skin disease accompanied by 
severe itching, can lead to serious impairment of quality of life in patients. It is a major public health 
problem that affects at least 15% of children and is characterized by cutaneous hyperreactivity to 
environmental triggers (Geha, 2003; Leung and Bieber, 2003; Novak et al., 2003). Pathological studies 
revealed spongiosis, hyperkeratosis and parakeratosis in acute lesions and marked epidermal 
hyperplasia and perivascular accumulation of inflammatory cells in chronic lesions. AD has a complex 
etiology that involves abnormal immunological and inflammatory pathways that include defective skin 
barrier, dry skin, exposure to environmental agents, and neuropsychological factors (Fartasch, 1997; 
Pastore et al., 1997; Trautmann et al., 2000; Geha, 2003; Leung and Bieber, 2003; Novak et al., 2003; 
Howell et al., 2004). Prevalence of atopic dermatitis has increased in recent years, but the 
pathophysiology of this condition is only partly understood and available treatments for this disorder are 
only palliative. 
 Pruritus, regularly defined as an unpleasant sensation provoking the desire to scratch 
(Rothman, 1941), is an essential feature of AD. Itch-elicited scratching aggravates lesions of the skin, 
and the itch is intensified. Therefore, reduction of itching would be one of the most effective strategies 
for management of AD (Kimura and Miyazawa, 1989; Wahlgren, 1999; Ikoma et al., 2006). However 
H1 receptor (histamine H1R) antagonists are used widely in the treatment of AD, they do not have 
sufficient inhibitory effect against pruritus (Wahlgren et al., 1990). Various studies have clearly shown 
that the number of cutaneous nerve fibers is altered in atopic skin lesions (Tobin et al., 1992; Sugiura et 
al., 1997; Urashima and Mihara, 1998) and this is probably caused by nerve growth factor (NGF), 
which is released from keratinocytes (Albers et al., 1994; Pincelli et al., 1994). Histamine does not 
therefore play a major role in pruritus treatment of patients with human AD, but its neuronal mechanism 
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is not fully understood. 
2. DS-Nh mouse 
 In 1976, DS-Nh mice were artificially selected on the basis of hairless phenotype from a 
colony of an inbred DS strain, which was developed from out-bred ddN stock obtained in 1954 from the 
Central Institute for Experimental Animals, Tokyo, Japan. DS-Nh mice develop spontaneous dermatitis 
when they are maintananced in conventional conditions and are considered to be a model of human AD 
(Fig. 1), with the following features: (i) superantigen-producing Staphylococcus aureus can be isolated 
from skin lesions; (ii) serum levels of IgE, interleukin (IL)-4 and IL-13 are significantly increased; (iii) 
numbers of whole mast cells and cluster of differentiation (CD) 4 positive T cells are significantly 
increased; (iv) serum and tissue levels of NGF are significantly increased; and (v) itch-associated 
behavior becomes significantly severe (Hikita at al., 2002; Yoshioka et.al., 2003 and 2006).  
 
 
 
 
 
Fig. 1 Clinical features of DS and DS-Nh mice. (a) DS (+/+) mice kept under conventional conditions (b, c) and DS-Nh 
(Nh/+, Nh/Nh) mice kept under specific pathogen-free condition. (d) Spontaneous dermatitis of DS-Nh mice kept under 
conventional conditions at 20 weeks. (e) A typical example of itch-associated behavior (sratching behavior) in mice (e). 
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 We have reported previously that DS-Nh mice have a one amino-acid substitution (Gly573 to 
Ser) in the transient receptor potential (TRP) cation channel subfamily V member 3 (TRPV3) and 
Gly573Ser substitution of TRPV3 is a gain-of-function mutation, as shown by the results of Ca
2+
 influx 
stimulated by temperature (Asakawa et al., 2006; Imura et al., 2007). Xiao et al. have speculated 
recently that Gly573Ser-substituted TRPV3 is active constitutively in vivo under normal physiological 
conditions (Xiao et al., 2008). Therefore, this mouse is thought to be good tool for investigating the 
association between activation of TRPV3 and development of dermatitis. 
 
3. TRPV3 
 The TRP channel superfamily contains 28 mammalian members (27 in human) subdivided in 
6 subfamilies: TRPC (canonical), TRPV (vanilloid), TRPM (melastatin), TRPP (polycystin), TRPML 
(mucolipin) and TRPA (ankyrin) (Fig. 2). TRP ion channels are widely expressed in many different 
tissues and cell types, where they are involved in diverse physiological processes, such as sensation of 
different stimuli or ion homeostasis (Nilius et al., 2007). Most TRPs are non-selective cation channels, 
only few are highly Ca
2+
 selective, some are even permeable for highly hydrated Mg
2+
 ions (Nilius and 
Owsianik, 2011). Members of the TRPV family comprise 6 ion channels based on homology. Four 
groups can be identified: TRPV1/TRPV2, TRPV3, TRPV4, and TRPV5/6. Among the TRPVs channels, 
TRPV1, 2, 3, and 4 have striking temperature sensitivities with activation threshold at 43 °C, 52°C, 
33°C and 30 °C, respectivery (Voets, 2012). TRPV3, a channel that has high sequence homology and 
located in the same chromosome as TRPV1 was identified using expressed sequence tag (EST) clones 
by three different groups simultaneously (Peier et al., 2002; Smith et al., 2002; Xu et al., 2002). After its 
identification, it appeared as a surprise that this channel was not highly expressed in the sensory dorsal 
root (DRG) or trigeminal (TG) ganglia (at least in rodents). Instead, TRPV3 was found to be most 
abundantly expressed in the skin, especially in epidermal and hair follicle keratinocytes (Peier et al., 
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2002). In vivo study, it was shown that TRPV3 deficient mice exhibit loss of behavioral responses to 
innocuous and noxious heat but not in other sensory modalities (Moqrich et al., 2005) and 
TRPV3
gly573ser
 mice spontaneously develop hairless phenotype. It is also reported that TRPV3 is 
involved in normal hair development and epidermal barrier formationin in mice (Cheng et al., 2010). 
With respect to skin physiology and pathophysiology, probably TRPV3 is the most important TRPV 
channel (Nilius and Bíró, 2013). However, detailed functions of TRPV3 in various diseases and its 
therapeutic potential have not been fully understood yet. 
 
 
 
 
 
Fig. 2 A phylogenetic tree of human TRP channels. (Nilius and Owsianik, 2011) 
  
 - 6 - 
 
 
 Therefore, these studies are conducted with the aim of investigation of pathophisiological role 
of TRPV3 in the skin by analyzing phenotype in DS-Nh and TRPV3 knockout mice. Chapter 1 attempts 
to illustrate that TRPV3 is involved in a certain type of itch. Chapter 2 describes that TRPV3 regulates 
dendritic cell migration and release of thymic stromal lymphopoietin (TSLP) from keratinocytes. 
Chapter 3 shows that physiolosical response of TRPV3 to various stimulations by pruritogen and irriant 
to the skin.  
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Chapter 1 Impact of TRPV3 on spontaneous itch in a mouse model of dry skin 
 
 Itch is a common symptom in various forms of dermatitis characterized by dry skin, such as 
senile xerosis and atopic dermatitis. It is defined as an unpleasant sensation that provokes a desire to 
scratch and, since itch-elicited scratching aggravates lesions of the skin, the itch is intensified (Ikoma et 
al., 2006). Therefore, reduction of itching and scratching is an effective strategy for preventing 
aggravation of skin lesions and improving quality of life. Histamine is the best-known pruritogen and 
has been regarded as a main target for antipruritic therapies, but H1 receptor (histamine H1R) 
antagonists are often ineffective against certain kinds of pruritus including dry skin pruritus (Wahlgren 
et al., 1990). It is suggested that mediators other than histamine also play a key role in itch; for example, 
physiological temperature, inflammatory mediators and nitric oxide. These putative pruritogens are also 
recognized as activators of TRPV3 (Xu et al., 2002; Hu et al., 2006; Yoshida et al., 2006), which is a 
warm-sensitive Ca
2+
-permeable cation channel highly expressed in epidermal keratinocytes (Peier et al., 
2002). Interestingly, we indicated previously that a gain-of-function mutation in TRPV3 caused itchy 
dermatitis in rodents (Asakawa et al., 2005 and 2006; Yoshioka et al., 2009). However, we could not 
sufficiently suggest a possibility of TRPV3 as a therapeutic target of pruritus. Hence, I focused on 
TRPV3 as a new therapeutic target for histamine H1R antagonist-resistant pruritus and carried out 
experiments using ICR
TRPV3-/-
 mice to determine the maximum therapeutic impact of TRPV3 for a 
certain type of itch. 
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1. Materials and Methods 
 
1-1. Animals 
 ICR mice and C57BL/6 mice were used. C57BL
TRPV3-/- 
mice were constructed according to 
previous report (Moqrich et al., 2005). C57BL
TRPV3-/-
 mice were crossed with ICR, since ICR mouse is a 
good responder for scratching behavior against various pruritogens (Inagaki et al., 2001). These F1 
progenies without TRPV3 backcrossed with ICR for several generations to produce ICR
TRPV3-/-
 mice. 
All mice used in this study were maintained in cages, exposed to a 12 hours light/12 hours dark cycle 
and provided with standard food and water ad libitum. This study was conducted according to the 
Guidelines for Animal Experimentation at Shionogi & Co., Ltd. 
 
1-2. Drugs 
 Naltrexone hydrochloride (Sigma-Aldrich, St. Louis, MO) were dissolved in physiological 
saline in a concentration of 0.1 mg/mL and injected subcutaneously in a volume of 0.1 mL per body 
weight of 10 g (10 mg/kg) into the caudal part of the back 15 minutes before the start of videotaping. 
Physiological saline was injected as the control. 
 
1-3. Treatment of cutaneous barrier disruption  
 Recently, Miyamoto et al. developed a murine model of dry skin pruritus, which was 
constructed by daily treatment of an acetone/ether (1:1) mixture and water (AEW) applied to the rostral 
back and the resulting spontaneous scratching of these models were thought to be 
histamine-independent (Miyamoto et al., 2002). The hair of mice was shaved over the rostral part of the 
back at least 4 days before the start of the experiment. The skin was treated by applying a piece of 
cotton soaked with a mixture of acetone and diethylether (1:1(v/v)) directly onto the shaved area for 15 
seconds, followed immediately by application of a piece of cotton soaked with distilled water to the 
 - 9 - 
 
exact same skin area for 30 seconds. AEW treatments were performed twice daily for 4 consecutive 
days.  
 
1-4. Measurement of TEWL and SC hydration 
 Skin dryness and barrier disruption after AEW treatment were determined by measuring 
transepidermal water loss (TEWL) for 30 seconds using a Tewameter
®
 TM300 (Courage & Khazawa, 
Cologne, Germany) or stratum corneum (SC) hydration expressed as relative capacitance using 
Moisture checker MY-808S (Scalar, Tokyo, Japan). Each parameter was measured on the day before the 
first treatment for cutaneous barrier disruption. 
 
1-5. Behavioral observation 
 After the 4th treatment day, the mice were put individually into an acrylic box composed of 
six cells. They were acclimated to the experimental environment for at least 1 hour, and then behaviors 
were videotaped for 2 hours with experimenters kept out of the observation room. Playing back of the 
video served for counting scratching behavior. The mouse generally scratches several times for about 1 
sesond and a series of these movements was counted as one bout of scratching. Locomotor activity were 
also measured over a 6 hour period as the amounts of spontaneous motor activity in both mice strains 
without AEW treatment using Activity Sensor Model NS-AS01 (NeuroScience, inc., Tokyo, Japan).  
 
1-6. Histopathological analysis 
 The dorsal skin was excised and fixed with 10% neutral formalin, embedded in paraffin and 
sectioned at 4 µm. The sections were stained with hematoxylin and eosin for histopathological analysis 
by light microscopy. Paraffin sections were also prepared for immunohistochemical analyses. These 
sections were pretreated with 2.5 mg/mL of purified mouse IgG (BD Pharmingen, San Diego, CA) in 
phosphate-buffered saline (PBS) containing 1% bovine serum albumin and Dako Protein Block (Dako, 
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Glostrup, Denmark). Next, the sections were immunostained with a rabbit anti-mouse protein gene 
product (PGP) 9.5 (Biomol, Plymouth Meeting, PA). After washing in Tris buffered saline-0.05% 
Tween 20 (TBS-T), the sections were reated with biotin-conjugated secondary antibodies (BD 
Pharmingen). After washing with PBS, the sections were treated with UltraAvidin-Horseradish 
Peroxidase (Leinco Technology Inc., St. Louis, MO). Finally, antibody-positive cells in the sections 
were visualized by enzyme-based color staining after washing with PBS. 
 
1-7. RT-PCR 
 Total RNA from back skin was extracted using TRIzol reagent (Invitrogen/GIBCO Life 
Technologies, Carlsbad, CA). Approximately 1 µg of total RNA was reverse transcribed with 
PrimeScript
®
 RT reagent Kit (Takara Bio, Shiga, Japan) and realtime PCR was performed with SYBR
®
 
Premix Ex Taq™ II (Takara Bio) using 1µL of cDNAs from each sample as template in a DNA thermal 
cycler (ABI7700; Applied Biosystems, Foster City, CA). The primer pairs for β-actin and Semaphorin 
3A were also purchased from Takara Bio.  
 
1-8. Western blotting 
 Skin tissue samples were collected from ICR
TRPV3+/+
 and ICR
TRPV3-/-
 mice, homogenized in 
M-PER Mammalian Protein Extraction Reagent (Pierce, Rockford, IL) and stored at −80°C until 
analysis.  The concentration of protein in homogenate was determined using a BCA reagent (Pierce). 
Samples were diluted with Laemmli Sample Buffer (Bio-Rad, Hercules, CA) and voiled for 5 min. Ten 
micrograms of proteins loaded onto a 4-12% NuPAGE
®
 Novex Bis-Tris Gel (Invitrogen). After 
electrophoresis, the proteins were electrotransferred onto polyvinylidene difluoride membranes 
(Invitrogen) overnight at 4°C. The membranes were incubated in blocking buffer (TBS-T with 4% w/v 
fat-free dry milk) for 2 hours at room temperature. The membranes were then incubated with the 
primary antibodies for 1.5 hours at room temperature. Primary antibodies used were rabbit anti-Sema 
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3A (1:100; Santa Cruz Bioechnology, Santa Cruz, CA) and rabbit anti-actin (1:1000; Santa Cruz 
Biotechnology). After incubation, the membranes were washed with TBS-T (TBS and 0.05% Tween 20) 
four times for 10 minutes and incubated with anti-rabbit HRP-conjugated secondary antibody (1: 2000; 
Santa Cruz Biotechnology) for 1 hour at room temperature. The membrane was then washed with 
TBS-T four times for 15 minutes. The immunoreactive proteins were detected by enhanced 
chemiluminescence (ECL kit; Amersham Biosciences, Arlington Heights, IL). The bands were 
quantified a lumminoimage analayzer (LAS 1000-Mini; Fuji Film, Tokyo, Japan).  
 
1-9. Statistics  
 All data are shown as the values of means and SEM. Statistical significance was tested by a 
Student’s t-test for non-paired samples or a paired t-test for paired samples. For multiple comparisons, 
analysis of variance (ANOVA) was performed followed by a post hoc test (Dunnett’s test). 
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2. Results and Discussion 
 
 C57BL
TRPV3-/-
 mice were constructed according to previous report (Moqrich et al., 2005). Fig. 
3 shows simple schematic drawing of the TRPV3 wild-type and TRPV3 mutant allele and the results of 
genotyping. I indicated the minimal separation of both alleles and position and size for PCR primers to 
perform the genetic testing. C57BL
TRPV3-/- 
mice were crossed with ICR and these F1 progenies without 
TRPV3 backcrossed with ICR for several generations to produce ICR
TRPV3-/-
 mice. Mice lacking the 
TRPV3 gene also exhibit wavy whiskers (Fig. 3c). I can distinguish between wild type (ICR
TRPV3+/+
) 
and ICR
TRPV3-/-
 mice based on these results. 
 
 
 
Fig. 3 Information regarding TRPV3 knockout mice and phenotypes associated with lack of TRPV3. (a) Simple 
schematic drawing of the TRPV3 wild-type and TRPV3 mutant allele. I indicated the minimal separation of both alleles 
and position and size for PCR primers to perform the genetic testing. (b) The results of genotyping. (c) Mice lacking the 
TRPV3 gene also exhibit wavy whiskers and dorsal coat.  
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 To develop skin dryness and barrier disruption, the dorsal back of ICR
TRPV3-/-
 mice and 
ICR
TRPV3+/+
 mice were treated with AEW for 4 days. Daily treatment with AEW increased 
transepidermal water loss (TEWL) and decreased SC hydration in both ICR
TRPV3+/+
 and ICR
TRPV3-/-
 mice 
(Fig. 4a). Hematoxylin-eosin (HE) staining revealed remarkable epidermal hyperplasia without 
infiltration of inflammatory cells in the dermis in both ICR
 TRPV3+/+
 and ICR
TRPV3-/-
 mice (Fig. 4b). It has 
been reported that TRPV3 is required for the formation of the stratum corneum layer, which is thought 
to be a key player in maintaining skin barrier functions (Cheng et al., 2010). Contrary to my 
expectations, there was no difference in the manner of the development of dry skin caused by AEW 
treatment between mice with and without TRPV3 in this study. This may be because the mouse strain 
used in each study was different or effects of AEW-treatment are too strong to detect the effects of 
TRPV3 on the development of dry skin.  
 
 
 
 
 
Fig. 4 Physiological and histological features of experimental dry skin induced by AEW in ICRTRPV3+/+ and 
ICRTRPV3-/- mice. (a) Changes of TEWL and SC hydration of daily treatment with AEW. Each value represents mean ± 
SEM for 8 mice. NS, not significant. (Student’s t-test) (b) The dorsal skin was excised and fixed with 10% neutral 
formalin, embedded in paraffin and sectioned at 4 m. Sections were stained with hematoxylin-eosin (HE). Scale bar = 
100 µm. 
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 To examine the impact of TRPV3-deletion in the development of spontaneous scratching 
behavior, I performed behavioral tests. Repeated treatment with AEW resulted in a significant increase 
in spontaneous scratching directed toward the AEW-treated area; which was suppressed by 
subcutaneous injections of naltrexone, a µ-opioid receptor antagonist (Fig. 5b). Given that µ-opioid 
receptor antagonists reduce experimentally-induced itch in humans (Heyer et al., 1997), spontaneous 
scratching behavior observed in the AEW-treated mice might reflect similar itch sensation in humans. 
In the AEW-treated ICR
TRPV3-/-
 mice, there was a smaller increase in numbers of scratching behaviors 
compared to those of wild-type mice (Fig. 5c). To rule out the possibility of a sedative effect, I also 
measured the spontaneous motor activity and could not find any locomotor effects evoked by TRPV3 
deletion in these mice (Fig. 5a). These results indicated that TRPV3 plays a pivotal role in the 
development of itch in mice with dry skin. 
 
 
 
 
Fig. 5 Spontaneous scratching induced by AEW and locomotor activity in ICRTRPV3+/+ and ICRTRPV3-/- mice. (a) 
Behavior was measured over a 6-hour period as the amount of spontaneous motor activity in both mice strains. Each 
value represents mean ± SEM for 8-16 mice. (b) Scratching behavior of ICR mice with and without AEW treatments was 
evaluated during a 2-hour observation period. Naltrexone (NTX, 10 mg/kg) was dissolved in saline and injected 
subcutaneously 15 minutes before behavioral observation. Each value represents mean ± SEM for 6 or 7 mice. **p<0.01 
when compared with control (CONT), ## p<0.01 when compared with saline (SAL). (c) Scratching behavior of 
ICRTRPV3+/+ and ICRTRPV3-/- mice with and without AEW treatments was evaluated during a 2-hour observation period. 
Each value represents mean ± SEM for 8-16 mice 
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 It is well known that increased nerve density is involved in producing pruritus. In AD patients, 
increased sprouting of epidermal C-fibers is seen, inducing hypersensitivity to itching, which aggravates 
the disease (Paus et al., 2006). In the present study, I also found that the density of the invasive nerve 
fibers in the skin was increased in AEW-treated mice by immunohistochemical examination of the 
sensory neurons using anti-PGP9.5 antibody (Fig. 6). PGP9.5-positive neurites in the dermis were more 
prominent in the AEW-treated skin of wild-type mice compared to that of ICR
TRPV3-/-
 mice, and some 
fibers expanded into the epidermal layer. These results suggested that TRPV3 affected nerve sprouting 
in dry skin.  
 
 
 
 
Fig. 6 Lower nerve response to AEW treatment in the skin of ICRTRPV3-/- mice. Frozen sections were prepared from 
dorsal skin samples obtained from ICRTRPV3+/+ and ICRTRPV3-/- mice and immunostained for mouse protein gene product 
9.5 (PGP9.5). Arrows indicate PGP9.5-expressing neurites. Bar = 100 m. 
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 Semaphorin3A (Sema3A), an axon guidance molecule, potently induces retraction of 
NGF-sensitive neurons among dorsal root ganglia neurons (Dontchev and Letourneau, 2002). It is 
reported that Sema3A expressed in keratinocyte may play a crucial inhibitory role for C-fiber 
elongation/sprouting in the upper layers of the epidermis in human and alleviates skin lesions and 
scratching behavior in NC/Nga mice (Fukamachi et al., 2011; Yamaguchi et al., 2008). The protein and 
mRNA expression levels of Sema3A in the skin of wild-type mice were significantly decreased by 
AEW-treatment, but no change is found in ICR
TRPV3-/-
 mice treated with AEW (Fig. 7). In addition, 
previous studies indicate that TRPV3 affects the production of epidermal NGF (Gopinath et al., 2005; 
Yoshioka et al., 2009). These results suggest that TRPV3 causes pruritus in lesional skin through nerve 
fiber expansion. In AD patients with pruritus, higher expressions of TRPV3 mRNA are observed 
compared to those without pruritus (data not shown). This suggests that TRPV3 is involved in human 
and murine pruritus in a similar manner. 
 
 
 
 
Fig. 7 Effects of AEW-treatment on Sema3A production in the skin of ICRTRPV3+/+ and ICRTRPV3-/- mice. AEW 
treatment was given to the hair-clipped skin of murine back twice a day for 4 days. (a) The expression levels of Sema3A 
mRNA were examined by RT-PCR and normalized with -actin. Dotted lines indicate the expression levels of Sema3A 
in non-treated murine skin. Each value represents mean ± SEM for 8 mice. (b) Typical examples and (c) the expression 
level of Sema3A were examined by western blotting and normalized with -actin. Dotted lines indicate the expression 
levels of Sema3A in non-treated murine skin. Each value represents mean ± SEM for 3 or 4 mice. *p<0.05, Student’s 
t-test, when compared with control (CONT).  
 - 17 - 
 
3. Summary 
 
1. Daily treatment with AEW increased TEWL and decreased SC hydration in both ICR
TRPV3+/+
 and 
ICR
TRPV3-/-
 mice. Remarkable epidermal hyperplasia without infiltration of inflammatory cells in the 
dermis was observed in both ICR
 TRPV3+/+
 and ICR
TRPV3-/-
 mice treated with AEW. 
 
2. Repeated treatment with AEW resulted in a significant increase in spontaneous scratching directed 
toward the AEW-treated area in ICR
 TRPV3+/+
 mice, however there was a smaller increase in 
AEW-treated ICR
TRPV3-/-
 mice compared to those of ICR
 TRPV3+/+
 mice. 
 
3. The density of the invasive nerve fibers in the skin was increased in AEW-treated mice and neurites 
in the dermis were more prominent in the AEW-treated skin of ICR
 TRPV3+/+
 mice compared to that of 
ICR
TRPV3-/-
 mice. 
 
4. The expression levels of Sema3A in the skin was significantly decreased by AEW-treatment in 
ICR
TRPV3+/+
 mice, but no change is found in ICR
TRPV3-/-
 mice treated with AEW  
 
 These results suggest that TRPV3 causes pruritus in lesional skin through nerve fiber 
expansion. Although I could not carry out pharmacological studies using TRPV3-antagonists to 
elucidate the therapeutic role of TRPV3 for a certain type of pruritus, I believe that this is the first report 
referring their role in itch sensation by genetic studies using ICR
TRPV3-/-
 mice. TRPV3 may play an 
important role in dry skin itch and TRPV3 antagonists could be a therapeutic option in managing AD 
and dry skin patients with histamine H1R antagonist-resistant pruritus. 
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Chapter 2 Impact of TRPV3 on the development of allergic dermatitis as a 
dendritic cell modulator 
 
 Inflammatory responses are one of the body's defense systems against harmful agents or 
injury and the classical signs of acute inflammation are pain, heat, redness and swelling. Although the 
thermal element of inflammation and/or fever might regulate the activation and migration of dendritic 
cells (DCs) in the skin (Ostberg et al., 2000), a detailed mechanism for this has not been reported. 
Cutaneous DCs, such as epidermal Langerhans cells (LCs) and dermal DCs play a major role in 
regulating skin immune responses. As professional antigen presenting cells, they detect exogenous 
substances that have penetrated the epithelial barrier and traffic to the draining lymph nodes (LNs) 
where they interact with T and B cells to initiate and shape adaptive immune responses. 
 DS-Nh mice were selected on the basis of a hairless phenotype from an inbred DS strain 
mouse colony, developed from an out-bred ddN stock. DS-Nh mice develop spontaneous dermatitis and 
are considered a model of human atopic dermatitis (AD) (Hikita et al., 2002; Yoshioka et al., 2003, 2006 
and 2007). We previously reported on a one amino-acid substitution (Gly573 to Ser) in the TRPV3 
(TRPV3
gly573ser
) of DS-Nh mice and showed that this is a gain-of-function mutation, as Ca
2+
 influx was 
stimulated by temperature (Asakawa et al., 2006). TRP channels are expressed in almost all organs of 
the body and act as cellular sensors for a variety of environmental and endogenous stimuli such as 
temperature, touch, pain, osmolarity, pheromones and taste (Clapham, 2003). TRPV3 is a 
Ca
2+
-permeable cation channel that is highly expressed in keratinocytes and activated by moderate 
thermal heating (≥ 32°C) in the range where warmth is sensed (Xu et al., 2002; Peier et al., 2002; Smith 
et al., 2002). Studies using TRPV3-deficient mice revealed that the TRPV3 channel is necessary for 
normal hair development, epidermal barrier formation, and thermosensation (Moqrich et al., 2005; 
Cheng et al., 2010). However, there have been few reports on specific ligands for TRPV3. 
 Results of DNA microarray (Table S1) and cytokine array (Fig. S1) analysis using 
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keratinocytes from DS, DS-Nh, TRPV3 knockout mice (TRPV3-/-) and their wild-type littermates 
(TRPV3+/+) as well as a previous study regarding DC migration (Ostberg et al., 2000) motivated me to 
investigate whether TRPV3 might be a key player in the development of dermatitis, acting as a DC 
modulator. I was also interested in determining which pathological conditions would still maintain 
expression of TRPV3 in lesional areas using skin samples from patients with AD as one of the 
DC-mediated skin disorders, although little is known about its direct and indirect involvement in human 
dermatitis via dermal DC. Taking this into account, I investigated the dermal DC-mediated phenotype 
using DS-Nh mice as a potentially useful model in which to validate the pathological or therapeutic role 
of TRPV3. 
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1. Materials and Methods 
 
1-1. Animals 
Male DS, DS-Nh, TRPV3 knockout (TRPV3-/-) mice in an ICR genetic background and their 
wild-type (TRPV3+/+) littermates (Yamamoto-Kasai et al., 2012) were used in this study. All mice were 
maintained in cages exposed to a 12 hours light/12 hours dark cycle and provided with standard food 
and water ad libitum. The animals were housed in rooms under specific pathogen-free or conventional 
conditions. This study was conducted according to the Guidelines for Animal Experimentation at 
Shionogi & Co., Ltd. 
 
1-2. Contact hypersensitivity 
 Mice were sensitized by painting 60 μL of 0.5% 2,4-dinitrofluorobenzene (DNFB, 
Sigma-Aldrich, St Louis, MO) in 4:1 acetone:olive oil (AOO) on the shaved abdomen of each animal. 
Seven days after sensitization, each mouse was challenged with 20 μL of 0.2% DNFB in AOO applied 
to the side of the ear. The control animals received AOO without DNFB. At 0 and 24 hours post-DNFB 
challenge, ear swelling was evaluated by measuring the ear thickness using a dial thickness gauge 
(Teclock, Nagano, Japan). 
 
1-3. Hematoxylin and eosin staining 
 Lesional and nonlesional skins from three female patients with AD were purchased from 
Asterand (Detroit, MI), and fixed in 10% neutral formalin. Ears were excised from DS mice and DS-Nh 
mice 24 hours after DNFB or vehicle challenge, fixed in 10% neutral formalin and embedded in paraffin. 
Sections were stained with hematoxylin and eosin (HE) for histopathological analysis using light 
microscopy. This study was conducted according to the Declaration of Helsinki principles and approved 
by the local Research Ethics Committee. 
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1-4. Reverse transcription polymerase chain reaction (RT-PCR) 
 Total RNA was extracted from human skin (Asterand) using an RNeasy kit (Qiagen, Valencia, 
CA) with DNaseI (Qiagen) treatment, and 1 µg of total RNA was used to synthesize cDNA using 
PrimeScript® 1st strand cDNA Synthesis Kit (Takara Bio, Shiga, Japan). The cDNA was then used for 
quantitative RT-PCR analysis performed using respective pairs of gene-specific primers for TSLP, 
TRPV3 and Homo sapiens hypoxanthine phosphoribosyltransferase 1 (HPRT1) genes. The primer pairs 
for TSLP, TRPV3, HPRT1 and SYBR
®
 Premix Ex Taq™ II were purchased from Takara Bio. 
 
1-5. FITC-induced cutaneous DC migration and fluorescence-activated cell sorting analysis of lymph 
node single-cell suspensions 
 Inguinal LNs were isolated from mice 16 hours after abdominal application of 400 μL of 0.5% 
fluorescein isothiocyanate (FITC; Sigma-Aldrich) in 1:1 acetone:dibutyl phthalate and cut on ice. Tissue 
pieces were then suspended in RPMI 1640 medium including Liberase DL (Roche Applied Science, 
Indianapolis, IN) and DNase I (Sigma-Aldrich) and incubated at 37°C for 20 minutes. The tissue was 
completely dissociated using a 70-µm cell strainer (BD Biosciences, Stockholm, Sweden) to obtain a 
single cell suspension. After Fc receptor blocking with the CD16/32 antibody (Ab) (BD Biosciences), 
cells were stained with anti-CD11c-PE (eBioscience, San Diego, CA), anti-CD49d-PE (BD 
Biosciences) and anti-Langerin-PE (Biolegend, San Diego, CA). Cells were resuspended in 
fluorescence-activated cell sorting (FACS) staining buffer (BD Biosciences) before acquisition on a 
FACSAria (BD Biosciences) 
 
1-6. Primary culture of keratinocytes 
 Trunk skins from mice with the hair removed were incubated in 0.5% collagenase (Wako, 
Osaka, Japan) solution for 1 hour at 37°C, and then incubated with 1000 U/mL Dispase I (Godo Shusei, 
Tokyo, Japan) solution for 1 hour at 37°C. After washing with PBS, skin fragments were pressed 
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through a 100-µm cell strainer (BD Biosciences). The cell suspension was centrifuged and cultured in 
keratinocyte growth medium-2 (KGM-2 BulletKit; Cambrex, Walkersville, MD) at 33°C and 5% CO2. 
The culture supernatant was collected 24 hours after the last medium change and used for cytokine 
analysis using the Bio-Plex suspension array system (Bio-Rad, Hercules, CA) their TSLP levels were 
measured using an ELISA kit (R&D Systems, Minneapolis, MN) according to the manufacturer’s 
instructions. Gene expression in keratinocytes from DS and DS-Nh mice strains was analyzed using 
Agilent microarray hybridization. Total RNA was isolated using TRIzol reagent (Invitrogen, Carlsbad, 
CA) and purified using RNeasy kits (Qiagen). Equal amounts of total RNA samples were pooled from 
six wells for each strain and cDNA was prepared using the Agilent kit (Agilent, Santa Clara, CA). 
cDNAs were then hybridized to immobilized mouse oligo microarrays and analyzed according to the 
manufacturer’s instructions (Agilent). 
 
1-7. Measurement of TSLP 
 Skin tissue samples were collected from DS and DS-Nh mice, homogenized in M-PER 
Mammalian Protein Extraction Reagent (Pierce, Rockford, IL) and stored at −80°C until analysis. After 
the homogenates were thawed and centrifuged, supernatants were collected and their TSLP levels were 
measured using an ELISA kit (R&D Systems) according to the manufacturer’s instructions. 
 
1-8. Statistics 
 Statistical analyses were performed using the Student’s t-test for paired comparisons, unless 
stated otherwise. 
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2. Results and Discussion 
 
 In Fig. S1, because the same degree of G-CSF, KC, MCP-1, and TNF-responses were 
observed in keratinocytes from TRPV3-/- mice compared with TRPV3+/+ mice, keratinocytes from 
TRPV3-/- mice were thought to be equally physiologically active. On the other hand, greater TSLP 
responses were observed in keratinocytes from TRPV3+/+ mice compared with TRPV3-/- mice. These 
results indicate that TRPV3 is a key player in regulating TSLP levels in keratinocytes. Detailed results 
of the TSLP response in keratinocytes are shown in Fig. 11b. I also analyzed the gene profiles of 
primary keratinocytes from DS and DS-Nh mice using DNA microarrays. In Table S1, the value of 
“DNA microarray fold (Nh / DS)” is not lower than 1.90 or higher than 0.60, and the value of “Raw 
(DS-Nh or DS)” is not less than 5000. To set these criterion values, gene expression data reflect the 
most important difference in function of these keratinocytes. Hence, the genes listed in Table S1 were 
thought to be closely related to the gain-of-function TRPV3 mutant. According to the references shown 
in table S1, underlined genes are thought to be associated with DC or DC-mediated dermatitis directly 
or indirectly. Hence I hypothesized that TRPV3 regulates immune cell migration in the skin. 
 
Fig. S1 Cytokine array analysis using keratinocytes from TRPV3-/- and TRPV3+/+ mice. Release of cytokines from 
keratinocytes of TRPV3-/- mice and TRPV3+/+ mice into culture medium was measured using cytokine analysis using 
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the Bio-Plex suspension array system and ELISA kits 
Table S1 Genetic analysis of the primary keratinocytes from DS-Nh and DS mice  
 
 
 
 In Fig. 8a, histological analysis of the clinical features of three human AD patients used for 
RT-PCR analysis and the characteristics of these patients are shown. The level of TRPV3 mRNA in 
lesional skins from patients with AD (Fig. 8c) suggests that TRPV3 plays a role in the development of 
human AD. With respect to skin physiology and pathophysiology, TRPV3 might be the most important 
TRPV channel (Nilius and Bíró, 2013). I observed an up-regulation of TSLP and TRPV3 mRNA in 
lesional skin samples compared with nonlesional skin samples from patients with AD (Fig. 8d and 8e). 
TSLP is an epithelial cell-derived cytokine that regulates T cell differentiation by conditioning DC 
maturation (Soumelis et al., 2002). It was also reported that TSLP expression in patients with AD was 
associated with LC migration and activation (Soumelis et al., 2002; Ito et al., 2012). In this study, I 
tested whether TRPV3 acted as a DC modulator by controlling the TSLP response in DS-Nh mice. 
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Fig. 8 Higher expression of TRPV3 and TSLP mRNA in the skin of patients with AD. (a) Skin sections from 
nonlesional skin (I, III, V) and lesional skin (II, IV, VI) of three patients with AD were stained with HE. Pairs of 
nonlesional and lesional skin (I-II, III-IV, V-VI) from the same patients are shown in the order corresponding to #01-03. 
Scale bar = 100 µm. (b) Skin samples were obtained from three female patients with AD and #01-03 indicates patient 
number. (c) Expression levels of thermo-TRP mRNA in lesional and skin from patients with AD were examined by 
RT-PCR. Expression of HPRT1 was used as a normalization control. Each value represents the mean ± SEM. The fold 
difference in expression of (d) TRPV3 and (e) TSLP mRNA between lesional (L) and nonlesional (NL) skin showed that 
there was a tendency for increased expression of these two mRNAs in lesional skin. Expression of HPRT1 was used as a 
normalization control.  
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 Since DCs are known to play an important role in the development of contact hypersensitivity 
(CHS), I compared DNFB-induced CHS responses in DS-Nh and DS mice. To induce CHS, DS and 
DS-Nh mice were sensitized with DNFB on day 0 and challenged with DNFB on day 7 as shown in Fig. 
9a. DNFB challenge in DS mice failed to provoke a CHS response, whereas in DNFB challenged 
DS-Nh mice induced marked ear redness and swelling (Fig. 9b). The ear thickness in DNFB-challenged 
DS-Nh mice was markedly increased compared with DNFB-challenged DS mice, and HE stained 
sections showed edema and inflammatory cell infiltration in DS-Nh mice (Fig. 9c and 9d). These results 
suggested that TRPV3 activation is involved in the enhancement of CHS responses in DS-Nh mice. 
 CHS is a DC-dependent T cell-mediated skin inflammation that develops in two distinct 
phases: the sensitization and elicitation phase. During the sensitization phase, haptens penetrating the 
skin are captured by resident LCs and dermal DCs that migrate to regional LNs and induce the 
activation of specific T cell precursors. In the elicitation phase, reexposure of the skin to the hapten 
activates specific T cells in the dermis and triggers the inflammatory process responsible for cutaneous 
lesions, which peaks at 24-48 hours after reexposure. Therefore, the difference in CHS responses 
between DS and DS-Nh mice may be partly related to DC function regulated by TRPV3.  
 - 27 - 
 
 
 
 
Fig. 9 TRPV3gly573ser enhanced DNFB-induced CHS. (a) CHS induction protocol. Mice were sensitized with DNFB by 
applying 60 L of 0.5% DNFB in acetone:olive oil (4:1) to the shaved abdomen of mice on day 0. On day 7, sensitized 
mice were challenged on the side of the ears with 0.2% DNFB and ear thickness was measured 24 hours later. (b) Ear 
appearance was compared between DS and DS-Nh mice 24 hours after challenge with 0.2% DNFB or vehicle (control). 
(c) Ear thickness was increased in DS-Nh mice challenged with DNFB, but not in DS mice challenged with DNFB. Each 
value represents the mean ± SEM of 4-10 mice. **p<0.01, Student’s t-test, compared with vehicle-challenged control 
groups (control). (d) DNFB-sensitized DS and DS-Nh mice were challenged with 0.2% DNFB and 24 hours later the ears 
were excised and fixed in formalin, and prepared sections were stained with HE. Representative images were captured 
using light microscopy. Scale bar = 100 µm. 
 
 
 Activated DCs bearing antigen migrate into the draining LNs to initiate T cell responses. T 
cells memorize the characteristics of the antigen and upon a second exposure induce CHS responses. I 
hypothesized that DC activation contributes to the enhancement of CHS responses in DS-Nh mice and 
evaluated the migration of FITC-bearing DCs to the draining LNs after FITC application to abdominal 
skin using FACS (Fig. 10). FITC, acting as a hapten, can induce DC maturation and mobilization, 
therefore FITC-induced DC migration assays have been used for in vivo studies (Macatonia et al., 1987; 
Kripke et al., 1990). The uptake and transport of FITC by DCs can be easily traced by its fluorescence 
and this system allows for the investigation of the entire pathway of DC migration, from the skin to the 
LN. FITC was painted on the shaved abdomen and inguinal LNs cells were isolated 16 hours later. As 
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shown in Fig. 10, the frequency of FITC-bearing cells among CD11c+ (DC marker) cells in the draining 
LNs was higher in DS-Nh mice (30.52%) than in DS mice (8.77%). Similar results were obtained 
among Langerin+ cells or CD49+ cells (42.81% vs. 11.44% and 49.83% vs. 14.21%, respectively). 
Langerin is a highly selective marker for LCs, a specialized subset of DCs that populate the epidermal 
layer of the skin and CD49 expression is indicative of DC maturation (Valladeau et al., 2000; 
Puig-Kröger at al., 2000). These data indicated that hapten-induced DC activation was enhanced in 
DS-Nh mice, suggesting that TRPV3 was involved in DC activation in the skin. 
 
 
 
 
 
Fig. 10 TRPV3gly573ser potentiates DC migration from skin to draining lymph nodes. DS and DS-Nh mice were 
administered 400 L of 0.5% FITC in acetone/dibutyl phalate (1:1) to the shaved abdomen and 16 hours later inguinal 
LNs were collected. Single-cell suspensions were prepared and stained with anti-CD11c/PE, anti-Langerin/PE, and anti- 
CD49/PE to identify infiltrating DCs, LCs and activated DCs. A higher frequency of FITC-bearing cells was detected 
from the draining lymph node of DS-Nh mice compared with controls.  
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 TSLP is an epithelial cell-derived cytokine that regulates T cell differentiation by conditioning 
DC maturation. I observed the up-regulation of TSLP mRNA in the lesional skin of patients with AD 
(Fig. 8e). Furthermore, it was previously reported that patients with AD expressed elevated TSLP levels 
in the epidermis (Sano et al., 2013; Soumelis et al., 2002). Thus, I measured the expression levels of 
TSLP in the skin of DS and DS-Nh mice using an ELISA. TSLP levels were significantly higher in 
DS-Nh mice compared with DS mice (Fig. 11a). To confirm whether TRPV3 was involved in the 
production/release of TSLP from keratinocytes, TSLP levels in supernatants from primary cultures of 
keratinocytes taken from TRPV3-/- mice and DS-Nh mice were measured. Fig. 11b shows that TSLP 
release from TRPV3-/- keratinocytes was significantly decreased compared with TRPV3+/+ 
keratinocytes and only TRPV3+/+ keratinocytes responded to the higher temperature (37°C) without 
any difference in cell activity (data not shown). Moreover, higher levels of TSLP released from 
keratinocytes of DS-Nh mice compared with DS mice were observed (Fig. 11b). These findings 
suggested that TRPV3 is an important player in the regulation of TSLP production by keratinocytes. 
Keratinocytes are activated upon encountering haptens and produce various chemical mediators, such as 
tumor necrosis factor , interleukin (IL)-1, and prostaglandin (PG) E2 that promote the migration and 
maturation of skin DCs (Cumberbatch et al., 1995 and 1997; Kabashima et al., 2003). Cytokines that are 
found at high levels in lesional skin in patients with DC-mediated allergic skin inflammation (i.e. IL-1, 
TNF-, IL-4 and IL-13) can also synergize to induce TSLP expression by keratinocytes (Bogiatzi et al., 
2007). Thus, keratinocytes may play a pivotal role in the development of CHS. 
 
 - 30 - 
 
 
Fig. 11 Essential role of TRPV3 in TSLP release from keratinocytes. (a) Ear samples collected from DS and DS-Nh 
mice were homogenized, and supernatant TSLP levels were measured using ELISA. Each value represents the mean ± 
SEM of 4 mice. *p < 0.05, Student’s t-test, compared with DS mice. (b) Release of TSLP from keratinocytes in 
TRPV3-/- and TRPV3+/+ mice (left) or DS and DS-Nh mice (right) into culture medium was measured using ELISA. 
Each value represents the mean ± SEM of 6-12 mice. *p < 0.05, **p < 0.01, Student’s t-test, compared with TRPV3+/+ 
mice or DS mice. ## p < 0.01, Student’s t-test, compared with TRPV3+/+ cultured at 33°C. 
 
 
 In this study, FITC-bearing cells were rarely observed in the LNs and CHS responses induced 
by DNFB were not observed in DS mice. This suggested that DNFB was insufficient to trigger a 
primary immune response in DS mice under these conditions. However, enhanced skin responses to 
DNFB were observed in DS-Nh mice, and skin TSLP levels were higher than in DS mice. TSLP 
expression in patients with AD was associated with LC migration and activation in situ, suggesting that 
TSLP may contribute directly to the activation of DCs, which may then migrate into the draining LNs 
and prime allergen-specific T cell responses (Soumelis et al., 2002). Taken together, high level 
constitutive expression of TSLP may have an important role in DC activation and result in the 
aggravation of allergic skin inflammation. TSLP was also shown to participate in innate immune 
reactions in AD-like inflammation and early control of innate immune responses before activation of 
adaptive immune responses by conventional T and B cells that perpetuate chronic skin inflammation. 
Therefore, TSLP may adequately alleviate acute exacerbations of AD (Park et al., 2013). 
 Camphor is a well-known TRPV3 agonist and commonly used as a topical antiphlogistic in 
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medicine. From this perspective, TRPV3 activation may be expected to reduce an inflammatory 
response, but the results of the present study indicated an opposite effect of TRPV3. More recently, 
mutations in TRPV3 (Gly573Ser) have been linked with a rare genodermatosis known as the Olmsted 
syndrome (Lin et al., 2012). Moreover, Sherkheli et al. reported that prolonged exposure to 
monoterpenoids resulted in agonist-specific desensitization of TRPV3, whereas the Nh mutation in 
TRPV3 is a “gain-of-function” one (Sherkheli et al., 2009). While the bicyclic monoterpenoids 
(camphor or 1,8-cineol) induced both acute desensitization and tachyphylaxis, monocyclic 
monoterpenoids (dihydrocarveol or menthol) preferentially induced only tachyphylaxis. However, while 
the molecular basis for these differences remain unknown, the finding itself points to important 
biophysical and pharmacological aspects of TRPV3 activity that is modulated by different 
desensitization profiles of ligands. Taking this into consideration, it is difficult to validate an orphan 
receptor such as TRPV3 by pharmacological methods using artificial ligands. Given this information, I 
decided to employ DS-Nh mice with genetically active TRPV3 as a good tool to study this orphan 
ion-channel. 
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3. Summary 
 
1. Analysis of data obtained from the gene profiles of primary keratinocytes from DS and DS-Nh mice 
using DNA microarrays revealed that immune cell trafficking genes were altered in DS-Nh 
compared with DS mice.  
 
2. TSLP and TRPV3 mRNA in the lesional skin from the patients with AD were up-regulated 
compared with those in non-lesional skin. 
 
3. Ear thickness in DNFB-challenged DS-Nh mice was markedly increased compared with 
DNFB-challenged DS mice. 
 
4. The frequency of FITC-bearing cells among CD11c/Langerin/CD49 positive cells in the draining LN 
was higher in DS-Nh mice than in DS mice. 
 
5. TSLP release from TRPV3-/- keratinocytes was significantly decreased compared with TRPV3+/+ 
keratinocytes and only TRPV3+/+ keratinocyte responded to higher temperature (37°C). The higher 
levels of TSLP released from keratinocytes of DS-Nh mice were also observed compared with DS 
mice. And the expression level of TSLP in the skin of DS-Nh mice was significantly higher 
compared with DS mice.  
 
 These results demonstrated that the augmentation of CHS in DS-Nh mice might be due to the 
enhanced migration capability of DCs and that TPRV3-activation was partly involved in DC migration 
by playing a role in the constitutive release of TSLP from keratinocytes. TSLP was also shown to 
participate in innate immune reactions in AD-like inflammation and early control of innate immune 
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responses before activation of adaptive immune responses by conventional T and B cells that perpetuate 
chronic skin inflammation. Therefore, TSLP may adequately alleviate acute exacerbations of AD (Park 
et al., 2013). Similar to DS-Nh mice, TRPV3 may play a part in the aggravation of dermatitis through 
the regulation of DC functions in human AD. In addition, we previously reported that a gain-of-function 
mutation of TRPV3 (TRPV3
gly573ser
) caused itchy dermatitis in rodents (Asakawa et al., 2006; Yoshioka 
et al., 2009) and may be a therapeutic target for pruritus (Yamamoto-Kasai et al., 2012). In conclusion, I 
believe that TRPV3 is a potential therapeutic target for certain types of dermatitis, via the management 
of inflammation and pruritus. 
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Chapter 3 Impact of TRPV3 on acute skin inflammation and pruritogen 
induced itch-related response in mice. 
 
 Skin is well-known for its functional role as a protective physical barrier. It is now considered 
that skin is far more than a mere container but rather is a dynamic organ that has other recognised 
functions, such as endogenous homeostasis, metabolism and sensory input. In addition, skin actively 
participates in immunological regulatory processes and inflammatory responses. However, some 
inflammatory or immunological reactions lead to chronic inflammation processes, such as psoriasis or 
to intolerable skin inflammation conditions, such as contact dermatitis, which requires medication 
(Robert and Kupper, 1999).  
 TRPV3 is highly expressed in epidermal keratinocytes and required for the formation of the 
skin barrier by regulating the activities of transglutaminases, a family of Ca
2+
-dependent crosslinking 
enzymes essential for keratinocyte cornification (Peier et al., 2002; Cheng et al., 2010). Moreover, we 
reported previously that the gain-of-function mutation of the trpv3 gene (TRPV3
Gly573Ser
) in 
keratinocytes is responsible for the development of a spontaneous hairless phenotype and pruritic, 
AD-like skin alterations in rodents (Asakawa et al., 2005 and 2006; Yoshioka et al., 2009). However, 
pathophysiological role of TRPV3 in various skin conditions have not been fully understood yet. Here, I 
elucidated the roles of TRPV3 in the acute itch and inflammation in the skin using DS-Nh mice and 
TRPV3 knockout mice. 
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1. Materials and Methods 
 
1-1. Animals 
 ICR mice, ICR
TRPV3-/-
 mice, C57BL mice, C57BL
TRPV3-/-
 mice, DS mice and DS-Nh were used 
(Yamamoto-Kasai et al., 2012). All mice used in this study were maintained in cages, exposed to a 12 
hours light/12 hours dark cycle and provided with standard food and water ad libitum. This study was 
conducted according to the Guidelines for Animal Experimentation at Shionogi & Co., Ltd. 
 
1-2. Recovery of skin barrier function 
 Skin barrier function was evaluated by measurement of Transepidermal water loss (TEWL) 
using a Tewameter
®
 TM300  (Courage & Khazawa, Cologne, Germany). The hair of mice was shaved 
over the rostral part of the back before the start of the experiment. Mice were anaesthetized with 
pentobarbital (50 mg/kg) and the dosal surface of the back was treated by tape stripping (TS) with 
cellophane tape (Scotch; Sumitomo 3M, Tokyo, Japan) until TEWL reached 40-50 g/m
2
/h). TEWL was 
measured just before, immediately after and at 1, 3 and 6 hours after tape stripping. The percentage of 
barrier recovery was calculated using the following formula: (TEWL immediately after tape stripping - 
TEWL at indicated time point)/(TEWL immediately after tape stripping - TEWL before tape stripping) 
× 100%. 
 
1-3. TPA-induced dermatitis in mice 
 The hair of mice was shaved over the rostral part of the back before the start of the experiment. 
Acute irritant dermatitis was induced by appliication of 100 µL of 0.006% (w/v) 
12-O-tetradecanoylphorbol-13-acetate (TPA; Sigma-Aldrich, St. Louis, MO) dissolved in acetone. The 
dorsal skin was excised 72 hours after TPA application and fixed with 10% neutral formalin, embedded 
in paraffin and sectioned at 4 µm. The sections were stained with hematoxylin and eosin for 
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histopathological analysis by light microscopy. The epidermal thickness was analyzed using Image-Pro 
Plus image analysis software (Media Cybernetics, Bethesda, MD). 
 
1-4. AA-induced mouse ear edema 
 The inflammatory response was induced by application of 20 µL of 1% or 3% (w/v) 
arachidonic acid (AA; Sigma-Aldrich) dissolved in acetone on the surface of ears. The ear thickness 
was measured with a dial thickness gauge (Teclock, Nagano, Japan) before and 15, 30, 60, 90, 120 
minutes after application of AA or acetone. 
 
1-5. Behavioral observation 
 Substance P (SP; Peptide Institute, Osaka, Japan) was dissolved in physiological saline at the 
dose of 50 and 100 nmol/site and Compound 48/80 (Sigma-Aldrich) was also dissolved in physiological 
saline at the dose of 1 and 3 µg/site and injected intradermally to the rostral back. Immediately after an 
intradermal (i.d.) injection, the mice were put individually into an acrylic box composed of six cells. 
They were acclimated to the experimental environment for at least 1 hour, and then behaviors were 
videotaped for 30 minutes with experimenters kept out of the observation room. Playing back of the 
video served for counting scratching behavior. The mouse generally scratches several times for about 1 
second and a series of these movements was counted as one bout of scratching.  
 
1-6. Statistics  
 All data are shown as the values of means and SEM. Statistical significance was tested by a 
Student’s t-test for non-paired samples or a paired t-test for paired samples. For multiple comparisons, 
analysis of variance (ANOVA) was performed followed by a post hoc test (Dunnett’s test).  
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2. Results and Discussion 
 
 Tape stripping (TS) of the stratum corneum, a long-standing technique used in dermatology 
research to induce epidermal damage, disrupts the cutaneous epithelial barrier and induces various 
biological responses in the skin as part of the homeostatic repair response (De Koning et al., 2012; Man 
et al., 1999). To develop skin barrier disruption, the dorsal back of C57BL
TRPV3-/-
 mice and their 
age-matched littermates (C57BL
TRPV3+/+
) were treated with TS. Multiple strips immidietely increased 
TEWL in both C57BL
TRPV3+/+
 and C57BL
TRPV3-/-
 mice and recovered 6 hours after TS (Fig. 12). 
Although it has been reported that TRPV3 is required for the formation of the stratum corneum layer, 
which is thought to be a key player in maintaining skin barrier functions (Cheng et al., 2010), there were 
no remarkable difference in skin repair response between C57BL
 TRPV3+/+
 and C57BL
TRPV3-/-
 mice. This 
may be because the effects of TS were too strong to detect the effects of TRPV3 on the skin barrier 
recovery. 
 
 
Fig. 12 Tape stripping-induced acute barrier disruption in C56BLTRPV3+/+ and C57BLTRPV3-/- mice. (a) TEWL 
recovery curve after tape stripping mouse skin. TEWL was measured just before, immediately after and at 1, 3 and 6 
hours after tape stripping. (b) Recovery rates of TEWL after TS. The percentage of barrier recovery was calculated using 
the following formula: (TEWL immediately after tape stripping - TEWL at indicated time point)/(TEWL immediately 
after tape stripping - TEWL before tape stripping) × 100%. Each value represents the mean ± SEM of 10 mice. 
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 Next, I examined the impact of TRPV3 on acute irritant dermatitis induced by TPA and AA. 
Mouse skin inflammation induced by TPA and AA is commonly used as an animal model for evaluation 
of anti-inflammatory activity (Murakawa et al., 2006; Young et al., 1984; Puigneró V and Queralt J, 
1997). The application of TPA to mouse skin stimulates inflammatory responses that are mediated by 
leucocyte infiltration. An early hallmark of skin irritation and local inflammation is thickening within 1–
4 hour due to increased vascular permeability, edema and swelling within the dermis. Secondarily, 
polymorphonuclear leukocytes migrate to the dermis within about 24 hours, and produce MPO, a 
marker enzyme of neutrophil granules, which can be quantified as a measure of the magnitude of 
neutrophil activation (De Vry et al., 2005). TPA applied to the rostral back skin of mice induced 
significant increase in the epidermal thickness and infiltration of inflammatory cells in both ICR
TRPV3+/+
 
and ICR
TRPV3-/-
 mice, but there is no apparent difference between ICR
TRPV3+/+
 and ICR
TRPV3-/-
 mice (Fig. 
13). 
 
 
 
Fig. 13 Acute irritant dermatitis induced by TPA in ICRTRPV3+/+ and ICRTRPV3-/- mice. (a) TPA were applied to the 
rostral back skin and 72 hours later the skins were excised and fixed in formalin, and prepared sections were stained with 
HE. Representative images were captured by light microscopy. Scale bar = 100 µm. (b) Epidermal thickness was 
increased in both ICRTRPV3+/+ and ICRTRPV3-/- mice treated with TPA. Each value represents means ± SEM of 4 mice. **p 
< 0.01, Student’s t-test, compared with acetone-treated control groups (acetone). NS, not significant. (Student’s t-test) 
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 A single topical application of AA to mice ears caused marked swelling within 15 min of AA 
application and was maximal at 30 min in a dose dependent manner (Fig. 14). Ear swelling of 
ICR
TRPV3-/-
 mice treated with AA was milder than that of ICR
TRPV3+/+
 mice (Fig. 14a and 14b), whereas 
the ear thickness in AA-challenged DS-Nh mice was markedly increased compared with DS mice (Fig. 
14c and 14d).  
 
 
 
 
 
Fig. 14 Effects of TRPV3 on ear swelling induced by AA in mice. Time-course of ear thickness after AA application in 
ICRTRPV3+/+ mice (a), ICRTRPV3-/- mice (b), DS mice (c) and DS-Nh mice (d). Ear thickness was measured before and 15, 
30, 60, 90, 120 minutes after application of AA or vehicle. Each value represents mean ± SEM for 4 or 5 mice.  
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 As previously described, topical application of TPA to the skin of mice promotes acute irritant 
dermatitis and inflammatory responses, including development of edema, initiation of oxidative stress 
and induction of pro-inflammatory cytokines, cyclooxygenase (COX) 2 and nitric oxide synthase (NOS) 
2 (Ho et al., 2007; Song et al., 2008). Previous studies have reported that TPA-induced cellular 
functions, such as NF-kB activation and protein kinase C, are responsible for the expression of 
proinflammatory cytokines and inflammatory enzymes (Cataisson et al., 2005; Ho et al., 2007; Auphan 
et al., 1995). On the other hand, some pharmacological studies and/or clinical experiences have 
demonstrated that biologically active metabolites of AA, which is a member of free fatty acids, such as 
prostaglandins (PGs) and leukotriens (LTs) play an important role in the development of a certain type 
of inflammatory skin disorders. Inhibitors of COX and lipoxygenase (LO) suppress acute inflammatory 
responses induced by AA, suggesting that metabolites of AA has important role in acute inflammation 
induced by AA, most probably related to LTC4 and LTB4 release (Inoue et al., 1988; Griswold et al., 
1991). Topical application of AA to the ear was caused acute swelling in ICR
 TRPV3+/+
 mice, whereas that 
in ICR
TRPV3-/-
 mice was relatively mild. Interestingly, higher response was observed in DS-Nh mice 
compared with DS mice. However, unlike AA, there was no difference of the skin inflammation induced 
by TPA between ICR
 TRPV3+/+
 and ICR
TRPV3-/-
 mice. Therefore there is a possibility that TRPV3 may less 
affect the expression of pro-inflammatory cytokines and inflammatory enzymes such as COX2 and 
NOS2 in the irritant skin inflammation, but control the activation or inactivation of enzymes which 
could metabolize AA such as 5-LO and this contribute to development of the acute edema induced by 
AA.  
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 To confirm that TRPV3 is involved in transmission of itch sensation itself, substance P (SP) 
and compound 48/80 known as potent pruritogen were injected intradermally to the rostral back and 
counted scratching behavior in ICR
 TRPV3+/+
 and ICR
TRPV3-/-
 mice. An intradermal injection of compound 
48/80 (1 or 3 g/site) and SP (50 and 100 nmol/site), but not saline, elicited scratching behavior to the 
injected skin by the hind paws; the effect peaked in the initial 10 minutes and almost subsided by 30 
minutes (Fig. 15b and 15d). The number of scratching induced by both SP and compound 48/80 was 
similar between ICR
 TRPV3+/+
 and ICR
TRPV3-/-
 mice (Fig. 15a and 15c).  
 
 
 
 
 
Fig. 15 Spontaneous scratching induced by pruritogen in ICRTRPV3+/+ and ICRTRPV3-/- mice.  The number of scratch 
bouts for 30 min induced by intradermal injection of compound 48/80 (a) and SP (c). The time course of scratching 
following compound 48/80 injection (b) and substance P(d). Each value represents mean ± SEM for 4-8 animals. * 
p<0.05,** p<0.01 vs SAL. (Dunnett's test) 
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 There are several possible sites of action of SP (the location of NK1 tachykinin receptors) in 
the skin. SP acts on mast cells to release histamine (Ebertz et al., 1987; Lowman et al., 1988) and the 
other cells such as macrophages (Lucey et al., 1994), keratinocytes (Koizumi et al., 1994) and 
endothelial cells (Bowden et al., 1994) are also potential site of action of intradermal SP to release 
itch-related mediator. SP also acts directly on the peripheral terminals of primary sensory neurons 
through NK1 receptors (Andoh et al., 1996). Compound 48/80, a condensation product of 
N-methyl-p-methoxyphenethylamine with formaldehyde, is well known as a peripheral pruritogen. It 
produces the itch sensation and causes degranulation of mast cells and results in the release of 
pruritogens such as histamine and leukotriene B4 (Andoh and Kuraishi, 1998). In this study, ICR
TRPV3-/-
 
mice exhibited scratching behavior following injection of SP and compound 48/80 as well as 
ICR
TRPV3+/+
 mice. In chapter 1, I indicated that TRPV3 is involved in dry skin pruritus associated with 
nerve fiber expansion in the epidermis via at least partly modulating expression of the nerve extension 
related molecules such as NGF and Sema3A. Taken together, it is suggested that TRPV3 has little 
influence on transmission of acute itch sensation induced by pruritogenic agents. 
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3. Summary 
 
1. Tape striping immediately increased TEWL in both C57BL
TRPV3+/+
 and C57BL
TRPV3-/-
 mice and 
recovered 6 hours after TS. However, there were no remarkable difference in skin repair response 
between C57BL
TRPV3+/+
 and C57BL
TRPV3-/-
 mice. 
 
2. TPA applied to the rostral back skin of mice induced significant increase in the epidermal thickness 
and inflammatory cells in both ICR
 TRPV3+/+
 and ICR
TRPV3-/-
 mice and there is no apparent 
difference between ICR
 TRPV3+/+
 and ICR
TRPV3-/-
 mice. 
 
3. Ear swelling of ICR
TRPV3-/-
 mice treated with AA was milder than that of ICR
 TRPV3+/+
 mice, 
whereas the ear thickness in AA-treated DS-Nh mice was markedly increased compared with DS 
mice. 
 
4. An intradermal injection of SP and compound 48/80 elicited scratching behavior to the injected 
skin by the hind paws, however the number of scratching induced by both SP and compound 48/80 
were similar between ICR
 TRPV3+/+
 and ICR
TRPV3-/-
 mice.  
 
 These results demonstrated that TRPV3 is seems to have little influence on skin barrier 
recovery and transmission of acute itch sensation induced by pruritogenic agents. Moreover, TRPV3 
may less affect the expression of pro-inflammatory cytokines and inflammatory enzymes such as COX 
and iNOS in the irritant skin inflammation, but modulate the activity of enzymes which could 
metabolize AA such as 5-LO and this contribute to maintenance of the skin physiology. In the inflamed 
tissues, AA is either released from the infiltrating lymphocytes or produced within the sensory fibers or 
skin cells following the activation of receptors by other inflammatory mediators. Although I could not 
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carry out analysis of skin levels of AA metabolite profiles or assessment of enzymes activity, TRPV3 
might play a part in the aggravation of dermatitis through control of its metabolism and TRPV3 
antagonists could be a therapeutic option in managing skin inflammation associated with AA. 
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Overview 
 
 DS-Nh mice have a one amino-acid substitution (Gly573 to Ser) in the TRPV3 and Gly573Ser 
substitution is a gain-of-function mutation. DS-Nh mice develop spontaneous dermatitis and are 
considered to be a model of human AD therefore this mouse is thought to be good tool for investigating 
the association between activation of TRPV3 and development of dermatitis. With these findings, 
TRPV3 might have important role in skin physiology and pathophysiology. However, detailed functions 
of TRPV3 in various skin diseases and a possibility of TRPV3 as a therapeutic target of pruritus have 
not been fully understood yet. Thus, in this study, I carried out the experiments using ICR
TRPV3-/- 
mice to 
determine the maximum therapeutic impact of TRPV3 for a certain type of itch and using DS-Nh mice 
to elucidate the role of TRPV3 in the development of DC-mediated skin inflammation. Moreover, To 
investigate pathophysiological role of TRPV3 in various skin conditions, I elucidated the roles of 
TRPV3 in the acute itch and inflammation in the skin using DS-Nh mice and TRPV3-/- mice. 
 In chapter 1, it was revealed that TRPV3 might be involved in dry skin pruritus through the 
nerve fiber expansion and a therapeutic potential of TRPV3 for a certain type of pruritus was suggested 
by genetic studies using ICR
TRPV3-/-
 mice. TRPV3 may play an important role in histamine independent 
itch and TRPV3 antagonists could be a therapeutic option in managing AD and dry skin patients with 
histamine H1R antagonist-resistant pruritus. 
 In chapter 2, I indicated that TRPV3 might regulate the function of dermal dendritic cells via 
release of TSLP form keratinocyte at least partly and be involved in exacerbation of allergic skin 
inflammation. There is a possibility that the increasing skin temperature seems to be strategically used 
by dermal DC through TRPV3 but not just a warning of some disease.  
 In chapter 3, I examined the physiological role of TRPV3 in the skin. TRPV3 is unlikely to 
have a significant impact on skin barrier recovery and transmission of acute itch sensation induced by 
pruritogenic agents, however might control the activity of enzymes which metabolize AA such as 5-LO 
 - 46 - 
 
in the irritant skin inflammation. This function of TRPV3 might contribute to maintenance of the skin 
physiology and play a part in the aggravation of dermatitis. I therefore think that TRPV3 has a 
therapeutic potential for dermatitis involving AA and its metabolites. 
 
 
Fig. 16 The pathophysiological mechanism related to TRPV3 in itchy dermatitis.  
 
 In conclusion, the role of TRPV3 in a certain type of itch and dermal DC activation were 
firstly defined, and the physiological role of TRPV3 which may control the activity of 
lipid-metabolizing enzyme was revealed. These observations provide new insight into mechanisms 
responsible for the development of skin inflammation in allergic dermatitis and suggested therapeutic 
potential for pruritus. I believe that TRPV3-targered drugs become a useful and effective therapy for AD, 
via the management of inflammation and pruritus. 
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